1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Revisiting substance P in migraine : a methodological approach inspired by anti-CGRP and anti-PACAP success
- Contribution to journal › Article
- 2024
-
Mark
Therapeutic Effects of IL-1RA against Acute Bacterial Infections, including Antibiotic-Resistant Strains
- Contribution to journal › Article
- 2021
-
Mark
Neurokinins and their receptors in the rat trigeminal system : Differential localization and release with implications for migraine pain
- Contribution to journal › Article
- 2019
-
Mark
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
- Contribution to journal › Article
- 2018
-
Mark
Substance P represents a novel first-line defense mechanism in the nose
- Contribution to journal › Article
- 2014
-
Mark
Psychological aspects of patients with psoriasis: Biological and clinical studies
- Thesis › Doctoral thesis (compilation)
- 2009
-
Mark
Ototoxicity on cochlear nucleus neurons following systemic application of gentamicin
- Contribution to journal › Article
-
Mark
Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms
- Contribution to journal › Article
- 2007
-
Mark
Magnetic CLEAR supports for solid-phase synthesis of peptides and small organic molecules
- Contribution to journal › Article
- 2006
-
Mark
Pathway-specific bidirectional regulation of Ca2+/calmodulin-dependent protein kinase II at spinal nociceptive synapses after acute noxious stimulation.
- Contribution to journal › Article
